These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28087723)

  • 1. Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial).
    Sanghvi KP; Kabra NS; Padhi P; Singh U; Dash SK; Avasthi BS
    Arch Dis Child Fetal Neonatal Ed; 2017 Sep; 102(5):F389-F394. PubMed ID: 28087723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.
    Phelps DL; Watterberg KL; Nolen TL; Cole CA; Cotten CM; Oh W; Poindexter BB; Zaterka-Baxter KM; Das A; Lacy CB; Scorsone AM; Walsh MC; Bell EF; Kennedy KA; Schibler K; Sokol GM; Laughon MM; Lakshminrusimha S; Truog WE; Garg M; Carlo WA; Laptook AR; Van Meurs KP; Carlton DP; Graf A; DeMauro SB; Brion LP; Shankaran S; Orge FH; Olson RJ; Mintz-Hittner H; Yang MB; Haider KM; Wallace DK; Chung M; Hug D; Tsui I; Cogen MS; Donahue JP; Gaynon M; Hutchinson AK; Bremer DL; Quinn G; He YG; Lucas WR; Winter TW; Kicklighter SD; Kumar K; Chess PR; Colaizy TT; Hibbs AM; Ambalavanan N; Harmon HM; McGowan EC; Higgins RD;
    JAMA; 2018 Oct; 320(16):1649-1658. PubMed ID: 30357297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial.
    Bührer C; Erdeve Ö; Bassler D; Bar-Oz B
    BMJ Open; 2018 Jul; 8(7):e021749. PubMed ID: 29982217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when?
    Ozturk MA; Korkmaz L
    Int Ophthalmol; 2019 Sep; 39(9):1921-1930. PubMed ID: 30229439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term Refractive Effects of Propranolol Hydrochloride Prophylaxis on Retinopathy of Prematurity in Very Preterm Newborns.
    Korkmaz L; Karaca C; Akin MA; Bastug O; Sahiner M; Ozdemir A; Gunes T; Ozturk MA; Kurtoglu S
    Curr Eye Res; 2018 Feb; 43(2):213-217. PubMed ID: 29135357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome.
    Chaudhari S; Patwardhan V; Vaidya U; Kadam S; Kamat A
    Indian Pediatr; 2009 Mar; 46(3):219-24. PubMed ID: 19179740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human milk feeding prevents retinopathy of prematurity (ROP) in preterm VLBW neonates.
    Manzoni P; Stolfi I; Pedicino R; Vagnarelli F; Mosca F; Pugni L; Bollani L; Pozzi M; Gomez K; Tzialla C; Borghesi A; Decembrino L; Mostert M; Latino MA; Priolo C; Galletto P; Gallo E; Rizzollo S; Tavella E; Luparia M; Corona G; Barberi I; Tridapalli E; Faldella G; Vetrano G; Memo L; Saia OS; Bordignon L; Messner H; Cattani S; Della Casa E; Laforgia N; Quercia M; Romeo M; Betta PM; Rinaldi M; Magaldi R; Maule M; Stronati M; Farina D;
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S64-8. PubMed ID: 23809355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial.
    Manzoni P; Guardione R; Bonetti P; Priolo C; Maestri A; Mansoldo C; Mostert M; Anselmetti G; Sardei D; Bellettato M; Biban P; Farina D
    Am J Perinatol; 2013 Jan; 30(1):25-32. PubMed ID: 22773282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
    Nitkin CR; Bamat NA; Lagatta J; DeMauro SB; Lee HC; Patel RM; King B; Slaughter JL; Campbell JP; Richardson T; Lewis T
    JAMA Ophthalmol; 2022 Nov; 140(11):1085-1094. PubMed ID: 36201183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China.
    Chen Y; Li XX; Yin H; Gilbert C; Liang JH; Jiang YR; Zhao MW;
    Br J Ophthalmol; 2008 Mar; 92(3):326-30. PubMed ID: 18303154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and laser therapy for retinopathy of prematurity in neonatal intensive care unit.
    Liu L; Tian T; Zheng CX; Ileana V; Ioana A; Tatiana C; Oana R
    World J Pediatr; 2009 Nov; 5(4):304-7. PubMed ID: 19911148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe retinopathy of prematurity and visual outcomes in British Columbia: a 10-year analysis.
    Schiariti V; Matsuba C; Houbé JS; Synnes AR
    J Perinatol; 2008 Aug; 28(8):566-72. PubMed ID: 18368058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral propranolol in early stages of retinopathy of prematurity.
    Bancalari A; Schade R; Muñoz T; Lazcano C; Parada R; Peña R
    J Perinat Med; 2016 Jul; 44(5):499-503. PubMed ID: 26845715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase.
    Parad RB; Allred EN; Rosenfeld WN; Davis JM
    Neonatology; 2012; 102(2):139-44. PubMed ID: 22710821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada.
    Isaza G; Arora S; Bal M; Chaudhary V
    J Pediatr Ophthalmol Strabismus; 2013; 50(1):27-32. PubMed ID: 23205771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.
    Filippi L; Cavallaro G; Fiorini P; Daniotti M; Benedetti V; Cristofori G; Araimo G; Ramenghi L; La Torre A; Fortunato P; Pollazzi L; la Marca G; Malvagia S; Bagnoli P; Ristori C; Dal Monte M; Bilia AR; Isacchi B; Furlanetto S; Tinelli F; Cioni G; Donzelli G; Osnaghi S; Mosca F
    BMC Pediatr; 2010 Nov; 10():83. PubMed ID: 21087499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinopathy of prematurity in infants < 32 weeks' gestation at birth in New South Wales in 1993 and 1994.
    Todd D; Cassell C; Kennedy J; John E
    J Paediatr Child Health; 1999 Aug; 35(4):355-7. PubMed ID: 10457291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and severity of retinopathy of prematurity in extremely premature infants.
    Isaza G; Arora S
    Can J Ophthalmol; 2012 Jun; 47(3):296-300. PubMed ID: 22687311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.